Overview

Bioequivalence Study of Two Products of Tenofovir Alafenamide 25 mg Film Tablet in Healthy, Adult, Human Subjects

Status:
COMPLETED
Trial end date:
2024-09-13
Target enrollment:
Participant gender:
Summary
To compare the bioavailability and characterize the pharmacokinetic profile of the sponsor's test product relative to that of reference product after single oral dose, fully replicate, bioequivalence study in normal, healthy, adult, human subjects under fed condition.
Phase:
PHASE1
Details
Lead Sponsor:
Humanis Saglk Anonim Sirketi
Treatments:
tenofovir alafenamide